News & Updates

Broad spectrum (BS) antianaerobic therapy shows greater and even longer-lasting effect on the lung microbiome of patients with cystic fibrosis, without achieving recovery of pulmonary function noted with narrow spectrum (NS) therapy, reports a study.

Individuals who receive supplementation with magnesium at higher concentrations show increased bone mineral density (BMD) at the hip and femoral neck, according to a systematic review and meta-analysis.

The oral selective Janus kinase 3 (JAK3) inhibitor ritlecitinib effectively prevents hair loss in people with alopecia areata (AA) compared with placebo, according to the ALLEGRO study presented at EADV 2021.

B-cell signalling suppression with tirabrutinib appears to promote remission in patients with refractory pemphigus, as shown in a phase II trial. Furthermore, treatment has reduced oral corticosteroid exposure over time without any major safety concerns.

The monoclonal antibody (mAb) combination therapy comprising BRII-196 and BRII-198 significantly reduced the risk of hospitalization and death by more than three-quarters in non-hospitalized COVID-19 patients who were at high risk of worsening illness, according to an interim analysis of the ACTIV*-2 trial presented at IDWeek 2021.

Onychomycosis has a substantial impact on the quality of life of patients and requires effective treatment, results of a systematic review have confirmed.